These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32764498)

  • 1. Multifunctional Roles of miR-34a in Cancer: A Review with the Emphasis on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer with Clinical Implications.
    Kalfert D; Ludvikova M; Pesta M; Ludvik J; Dostalova L; Kholová I
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-34 and gastrointestinal cancers: a player with big functions.
    Gao W; Zhou J; Morshedi M
    Cancer Cell Int; 2024 May; 24(1):163. PubMed ID: 38725047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC).
    Zhang J; Wang Y; Chen X; Zhou Y; Jiang F; Chen J; Wang L; Zhang WF
    Oncotarget; 2015 Apr; 6(10):7454-69. PubMed ID: 25762634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
    Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
    J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1.
    Nie J; Ge X; Geng Y; Cao H; Zhu W; Jiao Y; Wu J; Zhou J; Cao J
    Oncol Rep; 2015 Jul; 34(1):311-7. PubMed ID: 25954903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential.
    Nie D; Fu J; Chen H; Cheng J; Fu J
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinoma.
    Cui XB; Peng H; Li RR; Mu JQ; Yang L; Li N; Liu CX; Hu JM; Li SG; Wei Y; Laibo-Yin ; Zhou H; Li F; Chen YZ
    Oncotarget; 2017 Nov; 8(54):92454-92469. PubMed ID: 29190930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer.
    Kong J; Wang W
    Onco Targets Ther; 2020; 13():2855-2872. PubMed ID: 32308419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
    Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
    Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.
    Yang L; Song X; Zhu J; Li M; Ji Y; Wu F; Chen Y; Cui X; Hu J; Wang L; Cao Y; Wei Y; Zhang W; Li F
    Int J Oncol; 2017 Jul; 51(1):378-388. PubMed ID: 28534990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
    Jia LF; Gan YH; Yu GY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of microRNA-34a With High Incidence and Metastasis of Lung Cancer in Gejiu and Xuanwei Yunnan.
    Chen Y; Hou C; Zhao LX; Cai QC; Zhang Y; Li DL; Tang Y; Liu HY; Liu YY; Zhang YY; Yang YK; Gao CW; Yao Q; Zhu QS; Cao CH
    Front Oncol; 2021; 11():619346. PubMed ID: 33796457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast Cancer.
    Xie R; Wang M; Zhou W; Wang D; Yuan Y; Shi H; Wu L
    Med Sci Monit; 2019 Sep; 25():7149-7157. PubMed ID: 31544897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis.
    Li YL; Liu XM; Zhang CY; Zhou JB; Shao Y; Liang C; Wang HM; Hua ZY; Lu SD; Ma ZL
    Oncogenesis; 2017 Aug; 6(8):e372. PubMed ID: 28825720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.